NEW
YORK, June 17, 2024 /PRNewswire/ -- More than
400 supporters came together on Monday, June
10th at the Altman Building to raise more than
$400k for early detection ovarian
cancer research at the third annual Tina's Wish Runway for
Research. More than just a fashion show, the foundation's spring
event is a night of storytelling and fashion dedicated to funding
innovative scientific research for the prevention and early
detection of ovarian cancer, where guests learn more about the
signs and symptoms of ovarian cancer and the impact this disease
has on many.
During the event, twenty (20) models — ovarian cancer patients,
survivors, family members, researchers and doctors — walked the
runway and shared their stories of survival, pain and life's
purpose with the community. They showcased fabulous looks from
designers and brands including AREA, BATSHEVA, The Danes NY,
Estuardo Meda, LoveShackFancy,
Meghan Patrice Riley, Mirror Palais,
Rinat Brodach and Theory.
Previous Runway for Research events have inspired women to take
lifesaving action. White & Case attorney, Michele Meises, attended the first Runway for
Research in 2022 and it inspired her to advocate for herself after
learning about the symptoms. She was ultimately diagnosed with
ovarian cancer and now has no evidence of disease.
"Tina's Wish empowered me to advocate
for myself and detect ovarian cancer before it spread widely, which
ultimately saved my life," said Meises. "It was an honor to be able
to walk in the show in 2023 and to see my rockstar gynecologic
oncologist walk on Monday night."
Michele's doctor, Dr. Eloise
Chapman-Davis, Division Director of Gynecologic Oncology at
the New York-Presbyterian Hospital Weill Cornell Medical College
walked in Monday night's show in support of her patients – many of
which were in the show and audience – and to generate greater
awareness that there is no effective early detection screen for
ovarian cancer.
"This is a disease that desperately needs
both awareness and a reliable early detection test," said
Chapman-Davis. "Ovarian cancer is typically diagnosed in late
stages, when the 5-year survival rate is only 27%. If it is
diagnosed in Stage 1, the five-year survival is 92%. So, it is
urgent to develop an effective, routine early detection method for
ovarian cancer to give all women a fighting chance when getting
this diagnosis."
Tina's Wish is a national not-for-profit dedicated to funding
cutting-edge research for the early detection and prevention of
ovarian cancer and providing education and awareness about
gynecologic health. Since 2008, Tina's Wish has raised more than
$24 million. The Foundation now
annually funds $2.4 million of
scientific research to develop innovative prevention and diagnostic
strategies.
To see photos from the evening or donate, visit:
tinaswish.org/runway24
To learn more about Tina's Wish funded research, visit
tinaswish.org/grant-information
Contact: Caroline Wilson
Director, Events & Communications
Tina's Wish
cwilson@tinaswish.org
View original content to download
multimedia:https://www.prnewswire.com/news-releases/tinas-wish-runway-for-research-raises-400k-for-ovarian-cancer-early-detection-research-302174229.html
SOURCE The Honorable Tina Brozman Foundation for Ovarian Cancer
Research